Recalls / Active ingredient / Bisoprolol Fumarate
Bisoprolol Fumarate
5 FDA drug recalls involving the active ingredient “Bisoprolol Fumarate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2026-01-21 | Class II | Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactu | Unichem Pharmaceuticals USA Inc. |
| 2025-11-21 | Class III | Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 2.5 mg/6.25 mg, packaged as (a) 30-count bottles, ND | Glenmark Pharmaceuticals Inc., USA |
| 2023-10-20 | Class III | Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 5mg/6.25mg, 100-count Bottle, RX only, Manufactured | Glenmark Pharmaceuticals Inc., USA |
| 2021-03-15 | Class II | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLETS 2.5 mg/6.25 mg, 100-count bottles, Rx Only, Distributed by | Cardinal Health Inc. |
| 2017-10-02 | Class II | Bisoprolol Fumarate tablets, 5 mg, 30-count bottles, Rx only, Manufactured by: UNICHEM LABORATORIES, LTD. Pi | Unichem Pharmaceuticals Usa Inc |